Latest Breaking News On - Replicel life sciences inc - Page 3 : vimarsana.com

RepliCel Life Sciences : CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS - Form 6-K

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS For the three months ended March 31, 2023 and 2022 Notice of No Auditor. | May 31, 2023

United statesHong kongBritish columbiaLee bucklerDavid hallWhile the companyMainpointe pharmaceuticalsTechnology transfer agreementGiven the companyCompany stock option planCompany or replicelInternational accounting standards boardShare of the companyReplicel life sciences incVenture exchange theVenture exchange

Form 6-K REPLICEL LIFE SCIENCES For: May 18

Form 6-K REPLICEL LIFE SCIENCES For: May 18
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

British columbiaUnited kingdomUnited statesAndrew schutteReplicel life sciences incCommission file numberSecurities exchangeRegulationst ruleSecurities exchange act

Global Care Capital Inc : Global Care Capital Announces Appointment of Chief Financial Officer

Vancouver, British Columbia (Newsfile Corp. - February 23, 2023) - Global Care Capital Inc. (CSE: HLTH) (FSE: L6V2) (the "Company" or "Global Care") announces the appointment of Mr. Simon Ma as Chief

United statesUnited kingdomBritish columbiaDennis riedlSimon maHugh maddinBryce clarkReplicel life sciences incTierone consultancy corporationGem international resources incCompany contactUnited coal holdings ltdUniversity of british columbiaCanadian securities exchangeVenture exchangeVentures inc

RepliCel Provides Corporate Update

RepliCel Provides Corporate Update
theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomHong kongBritish columbiaPeter lowryKevin mcelweeDavid hallBen austringAndrew schutteR lee bucklerAgency for medical innovations in feldkirchReplicel life sciences incMainpointe pharmaceuticalsCompany focus on transformational milestonesVenture exchangeRegulation services provider

RepliCel Life Sciences, Inc : RepliCel Provides Corporate Update

Company Focus on Transformational MilestonesVANCOUVER, BC / ACCESSWIRE / November 28, 2022 / RepliCel Life Sciences Inc. (TSXV:RP)(OTC PINK:REPCF) ("RepliCel" or the "Company"), a company developing next-generation

Nordrhein westfalenUnited statesUnited kingdomHong kongBritish columbiaPeter lowryKevin mcelweeDavid hallBen austringAndrew schutteR lee bucklerAgency for medical innovations in feldkirchReplicel life sciences incMainpointe pharmaceuticalsCompany focus on transformational milestonesVenture exchange